Iqvia Holdings Inc   (IQV)
Other Ticker:  
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
Price: $250.0862 $1.25 0.501%
Day's High: $252.51 Week Perf: 1.11 %
Day's Low: $ 248.83 30 Day Perf: 14.71 %
Volume (M): 111 52 Wk High: $ 252.51
Volume (M$): $ 27,696 52 Wk Avg: $209.47
Open: $248.55 52 Wk Low: $167.42

 Market Capitalization (Millions $) 46,587
 Shares Outstanding (Millions) 186
 Employees 79,000
 Revenues (TTM) (Millions $) 14,984
 Net Income (TTM) (Millions $) 1,358
 Cash Flow (TTM) (Millions $) 160
 Capital Exp. (TTM) (Millions $) 649

Iqvia Holdings Inc
IQVIA Holdings Inc. is a global provider of innovative solutions and services to the biopharmaceutical and healthcare industries. It was formed by the merger of Quintiles, a leading clinical research organization, and IMS Health, a healthcare data and analytics provider. The company is headquartered in Durham, North Carolina, United States, and has operations in more than 100 countries around the world.

IQVIA is a leading provider of clinical trial services, including clinical research and development, clinical trial execution, data management, and patient recruitment. The company also provides a range of commercial services, including market research, sales and marketing effectiveness, and commercial operations.

IQVIA has an extensive portfolio of proprietary data assets, including the largest healthcare database in the world, with over 1 billion patient records. This database allows the company to provide insights into healthcare trends, identify patient populations for clinical trials, and help clients make informed decisions about product development and commercialization.

The company's client base includes pharmaceutical and biotech companies, medical device manufacturers, healthcare providers, payers, and government agencies. IQVIA works closely with its clients to help them develop and bring to market innovative and effective healthcare solutions.

In addition to its core business, IQVIA is committed to advancing healthcare through a range of social responsibility initiatives. These include programs to address health disparities, promote diversity and inclusion, and support underserved communities around the world.

IQVIA has a global workforce of approximately 67,000 employees, many of whom are highly educated and skilled professionals, including scientists, clinicians, and data analysts. The company has a strong culture of innovation, collaboration, and continuous learning, and is committed to ensuring that its employees have the skills and resources they need to serve its clients and make a positive impact on healthcare globally.

   Company Address: 2400 Ellis Rd. Durham 27703 NC
   Company Phone Number: 998-2000   Stock Exchange / Ticker: NYSE IQV

Customers Net Income grew by IQV's Customers Net Profit Margin grew to

3721.58 %

6.25 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
CMCSA        0.98% 
FYBR        10.94% 
T        2.56% 
TMUS   -0.01%    
VZ   -1.56%    
ZI        1.23% 
• View Complete Report

Iqvia Holdings Inc

Surpassing Expectations: Iqvia Holdings Inc Announces Significant 3.45% Revenue Surge in Q4 2023

Iqvia Holdings Inc, a prominent global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, recently reported impressive financial results for the quarter ended December 31, 2023. The company posted astonishing bottom-line earnings, with earnings per share improving significantly by 110.58% to $2.58 per share. Revenue also saw a moderate increase of 3.45% to $3.87 billion from the same quarter a year ago.
In comparison to the prior quarter, where the company realized revenue of $3.74 billion and bottom line of $1.63 per share, the growth in earnings and revenue in the fourth quarter is commendable. Net earnings for the financial interval ending December 31, 2023, increased by 106.61% to $469.000 million from $227.000 million reported in the same period a year ago.

Iqvia Holdings Inc

Iqvia Holdings Inc Emerges Victorious in Market Surge, Delivering Record-Breaking Financial Growth

Iqvia Holdings Inc, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, has experienced a significant increase in its share price over the past week and year. The company's shares recorded a solid gain of 5.87% over the course of the last five trading days and an impressive 203.86% over the past 12 months. Currently, Iqvia Holdings Inc shares trade 13.8% above their 52-week low.
These positive stock market performances are a reflection of the company's strong financial results for the period ending September 30, 2023. During this period, Iqvia Holdings Inc reported a 4.885% increase in revenue, reaching $3.74 billion compared to $3.56 billion in the same reporting season the previous year. Additionally, the company grew its earnings per share (eps) by 9.4% to $1.63, up from $1.49 in the prior year reporting season.

Iqvia Holdings Inc

IQVIA Holdings Inc Reports Gross Revenue Increase Amid Dwindling Industry Orders in Fiscal Q2 2023

Iqvia Holdings Inc Flourishes in Second Quarter Amidst Struggling Medical Laboratories Industry
Iqvia Holdings Inc, a leading provider of advanced analytics, technology solutions, and contract research services to the healthcare industry, has reported a strong performance in the second quarter of 2023. While many companies in the Medical Laboratories industry are facing challenging times with dwindling orders and fading top-line, Iqvia has exhibited impressive growth.
The company's revenue for the most recent fiscal period increased by 5.281% to $3.73 billion, compared to $3.54 billion in the prior year quarter. This growth in revenue is a positive indication of Iqvia's ability to secure new business and expand its market presence. Additionally, the company's income has shown significant improvement, increasing by 18.66% to $1.59 per share, compared to $1.34 in the prior year quarter.


Iqvia Holdings Inc's Segments
• View Complete Report
  Company Estimates  
  Revenue Outlook
Iqvia Holdings Inc does not provide revenue guidance.

Earnings Outlook
Iqvia Holdings Inc does not provide earnings estimates.

Geographic Revenue Dispersion


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com